CClinicalTrials.gg
CompletedNCT03475771Updated Mar 29, 2018

Retrospective Evaluation of Thrombo-embolic Complication in Pelvic Fracture Surgery

An observational study in Venous Thromboembolism and Pelvic Fracture, sponsored by Fondation Hôpital Saint-Joseph. Completed at 1 site in France. Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2018-03-29.

Sponsored by Fondation Hôpital Saint-Joseph · Observational

Study type
Observational
Model
Cohort
Time perspective
Retrospective
Enrollment
100
Ages
18 Years and older
Sex
All
01

Study summary

Pelvic fracture are very often treated by surgery ; however there are a high level of thrombotic risk during the surgery (venous thrombo embolic events represent about 10% to 50%.

The aim of our study is to report the number of these events and identify the risk factor associated to these events regarding Greenfield Risk Assessment Profile .

02

Conditions studied

03

Who can participate

Ages eligible
18 Years and older
Sexes eligible
All
Sampling method
Non-probability sample

Study population

patients admitted in GHPSJ orthopedy yard between december 2014 and january 2017

Inclusion criteria

  • indication to pelvic fracture surgery
  • age above 18 years

Exclusion criteria

Exclusion Criteria:

  • pelvic fracture without surgery indication.
04

Study design

Observational model
Cohort
Time perspective
Retrospective
Enrollment
100 participants (actual)
Patient registry
No
05

What researchers measure

Primary outcomes

  1. number of venous thrombo-embolic events

    Time frame: Month 1

06

Study locations

1 site
  • Groupe Hospitalier Paris Saint Joseph
    Paris, Ile-de-France 75014, France
07

Registry details

Key details

Study ID
NCT03475771
Lead sponsor
Fondation Hôpital Saint-Joseph
Responsible party
Sponsor
First posted
Mar 23, 2018
Start date
Mar 24, 2017
Primary completion
Dec 31, 2017
Completion
Jan 4, 2018
Last update
Mar 29, 2018

Study contacts

BONHOMME Stéphanie, MD
principal investigator · GHPSJ

Oversight

FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Mar 2018. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion